Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

84 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Completed

Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma

NCT00044759

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • Little Rock, Arkansas, United States
  • Los Angeles, California, United States
  • Denver, Colorado, United States
  • Gainesville, Florida, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

Optimizing PTCy Dose and Timing

NCT03983850

Conditions
Graft Versus Host Disease, Graft vs Host Disease, Hematologic Diseases, +5 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Active, Not Recruiting

Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant

NCT02477878

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +22 more
Locations
  • BMT Program at Northside Hospital Atlanta, Georgia, United States
  • University of Kansas Westwood, Kansas, United States
  • Roswell Park Buffalo, New York, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details

Related conditions